Todd Susan, Valdés-Márquez Elsa, West Jodie
Department of Mathematics and Statistics, University of Reading, Philip Lyle Building, Reading RG6 6BX, UK.
Pharm Stat. 2012 Mar-Apr;11(2):141-8. doi: 10.1002/pst.516. Epub 2012 Feb 15.
This paper presents practical approaches to the problem of sample size re-estimation in the case of clinical trials with survival data when proportional hazards can be assumed. When data are readily available at the time of the review, on a full range of survival experiences across the recruited patients, it is shown that, as expected, performing a blinded re-estimation procedure is straightforward and can help to maintain the trial's pre-specified error rates. Two alternative methods for dealing with the situation where limited survival experiences are available at the time of the sample size review are then presented and compared. In this instance, extrapolation is required in order to undertake the sample size re-estimation. Worked examples, together with results from a simulation study are described. It is concluded that, as in the standard case, use of either extrapolation approach successfully protects the trial error rates.
本文提出了在假定比例风险的情况下,针对具有生存数据的临床试验中样本量重新估计问题的实用方法。当在审查时能够轻松获取涵盖所有招募患者的完整生存经历数据时,结果表明,正如预期的那样,进行盲法重新估计程序很简单,并且有助于维持试验预先设定的错误率。然后介绍并比较了两种用于处理在样本量审查时仅有有限生存经历数据情况的替代方法。在这种情况下,需要进行外推以进行样本量重新估计。文中描述了实例以及模拟研究的结果。得出的结论是,与标准情况一样,使用任何一种外推方法都能成功保护试验的错误率。